Skip to content
Recall Observatory FDA recall evidence

Device product

FaStep COVID-19 IgG/IgM Rapid Test Device Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, plasma (sodium EDTA) and fingerstick whole blood. Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. (CLIA Waived Laboratories)

Z-2408-2021

July 27, 2021

Class II

Product summary

Firm
Versea Diagnostics LLC
Event
Event 88429
Status
Terminated
Classification
Class II
Quantity
563,290 in total
Official record key
device-enforcement:Z-2408-2021

Official wording

Reason: Products may have been distributed to customers other than laboratories certified under the Clinical Laboratory Improvement Amendments as stipulated in the Emergency Use Authorization.

Code information: all lot codes

Distribution pattern: US Nationwide Distribution: AL, AZ, CA, CO, CT, FL, GA, IL, KS, OH, OK, MA, MD, MI, NC, NJ, NY, PA, SC, TX, VA, and WA.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Products may have been distributed to customers other than laboratories certified under the Clinical Laboratory Improvement Amendments as stipulated in the Emergency Use Authorization.

Field note

Send feedback

We'll only use this to respond to your feedback.